Cellective Therapeutics

About:

Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.

Website: https://cellectivetherapeutics.com

Top Investors: Alta Partners, Sofinnova Investments, Intersouth Partners, Forward Ventures, Latterell Venture Partners

Description:

Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.

Total Funding Amount:

$27.5M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2003-01-01

Founders:

Dr. Thomas F. Tedder

Number of Employees:

Last Funding Date:

2004-09-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai